Академический Документы
Профессиональный Документы
Культура Документы
Not grow on
ordinary media,
grow slowly on
Lowestein-
Jensen medium /
LJ
Mycobacterium
Divided into two main groups
A- Typical / Tubercle bacilli
Mycobacterium tuberculosis
Mycobacterium bovis
Tuberculosis
Mycobacterium africanum
Mycobacterium leprae
Leprosy
Mycobacterium
B- Mycobacterium other than
tubercle bacilli (MOTT) /
Environmental mycobacterium ,
saprophytes or opportunistic
pathogens
Divided into 4 groups according to
their production of pigment & rate of
growth
Group I Photochromogens
Group II Scotochromogens
Slow growers
Mycobacterium Tuberculosis
Pathogenesis
Main virulence factor is the ability
to survive within macrophage
Immune response is cell-mediated
immunity
Protective immunity recovery
Nature of immune response change
with time
Mycobacterium Tuberculosis
Definition
Tuberculosis is a
chronic granulomatous
disease caused by three
related species
M. tuberculosis human
tubercle bacilli
M. bovis bovine tubercle
bacilli
M. africanum
intermediate form /
Mycobacterium Tuberculosis
Tuberculosis
Usually affects lung, but many other
organs may be affected
Incidence is increasing due to
emergence of AIDS cases
Mycobacterium Tuberculosis
Epidemiology
Human tuberculosis is
transmitted by inhalation
Bovine tuberculosis is
transmitted by ingestion of
contaminated milk
According to WHO
100 million infected yearly
8-10 million develop
disease
4-5 million become
Mycobacterium Tuberculosis
Clinical infections
Mycobacterium Tuberculosis
Primary tuberculosis
Inhalation of bacilli
↓
Replicate inside
macrophage
↓
(Ghon focus = initial
lesion )
MycobacteriumTuberculosis
Ghon focus
& Primary complex
Enlarged hilar LN
Activated macrophages
⇓
Fuse & form giant cell
⇓
Granuloma with necrotic center
Caseation
Primary complex Granuloma &
caseation
Mycobacterium Tuberculosis
Limit primary infection / not all bacilli
died some remain dormant
Few cases disseminate
meninges, bone, joint, kidney (Miliary
Tuberculosis)
Mycobacterium Tuberculosis
Post-Primary Tuberculosis
Reactivation or Reinfection
Often affect upper lobes of lung
Same granulomatous reaction but
more tissue necrosis
Cavitations
Bacilli gain access to sputum
Open TB / Infectious
Dissemination is unusual
Tuberculosis
Mycobacterium Tuberculosis
Mycobacterium Bovis
Ingestion of Bacilli
Primary complex involves
Tonsil & cervical lymph node
Scrofula
Intestine [ileocecal region]&
mesenteric lymph node
Primary Complex
Scrofula
Mycobacterium Tuberculosis
Tuberculin Test
Test done by using
Purified Protein
Derivative [PPD]
Intracutaneous
injection Mantoux
method
Used as Diagnostic
test, but with limited
usefulness?
Used to identify
patients who are
Treatment of Tuberculosis
First-line anti-tuberculosis drugs
Rifampicin + isoniazide +pyrazinamide
+/- ethambutol
Why Combination??
Action of anti-TB drugs depend on
population dynamic of MTB within the
lesion
Mutation to drug resistance occurs at
low & constant rate in all
mycobacterium population
Combination therapy is needed to
prevent selection of resistance & MDR-
Treatment of Tuberculosis
Three stages of replication
Free active replicating MTB in
cavity
Slowly replicating in
macrophage in acidic PH
Few are Dormant / Persister
Treatment of Tuberculosis
Antituberculosis drugs
Sterilizing Bacteristati
Bactericidal c
Pyrazinami Ethambutol P-
de Streptomyc aminosalicy
in lic acid
Treatment of tuberculosis
Anti-microbial activity of Anti-
TB
Isoniazide/ rapid bactericidal
against free replicating bacilli & no
effect against dormant bacilli
Pyrazinamide/ active at acidic PH
and kill slowly replicating bacilli
Rifampicin/kill dormant bacilli &
bactericidal against rapidly and
slowly replicating bacilli
Treatment of Tuberculosis
Treatment Regimen
Short courses are based on
intensive regimens
Intensive phase of Rifampicin +
Isoniazide + Pyrazinamide for 2
months if there is resistance
ehambutol may be used as fourth
drug
Continuation phase of Rifampicin +
Isoniazide for 6 months
Treatment of Tuberculosis
Three phases of response to
therapy
Phase 1( first 1-2 weeks)
Large No. of actively replicating
bacilli killed by mainly by Isoniazide
and Rifampicin
Phase 2 ( 2-8 weeks)
Less active bacilli are killed by
Rifampicin & Pyrazinamide
Phase 3 ( Continuation phase)
Control of Tuberculosis
Earlydetection & effective
treatment
Vaccination/ BCG
It is a living attenuated vaccine
Derived from M.bovis
It is given intracutaneously
Chemoprophylaxis
Contact with open TB
Isoniazide alone
Mycobacterium Leprae
Leprosy
Infection often causes severe
disfigurement & deformity
Still prevalent in some parts > 5
million case
Description
AFB/ like TB BUT
Not grow in any type of artificial
media /vitro
Mycobacterium Leprae
Pathogenesis
Target is nerve cells Nerve damage
The progression of the disease is
determined by immune response to
the bacilli
– Tuberculoid Leprosy (TT)/ few bacilli &
strong immune reaction
– Borderline Tuberculoid (BT)
– Borderline Lepromatous (BL)
– Lepromatous Leprosy (LL) / Many bacilli &
no immune response
Leprosy
MOTT/ Mycobacteria Other Than
tuberculosis bacilli
Divided into 4 groups according to
their production of pigment & rate
of growth
* Group I Photochromogens
* Group IV Rapid
MOTT/ Mycobacteria Other Than
tuberculosis bacilli
Treatment: